DJIA 17,899.20 94.40 0.53%
NASDAQ 4,771.98 6.60 0.14%
S&P 500 2,071.16 0.51 0.02%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

164.83 -5.34 (-3.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $164.65 -3.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.31
Previous Close $170.17
Daily Range $163.91 - $169.04
52-Week Range $108.20 - $173.14
Market Cap $125.4B
P/E Ratio 26.80
Dividend (Yield) $3.16 (1.9%)
Ex-Dividend Date
Dividend Pay Date
02/10/15
03/06/15
Volume 1,397,036
Average Daily Volume 3,393,296
Current FY EPS $8.59

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Buying These 3 Stocks Is Like Making a Bet in a Burning House

Aegerion Pharmaceuticals, MannKind Corp., and VIVUS, Inc. have all attracted short sellers in droves this year. With each company facing serious headwinds, should investors avoid these struggling biotechs?

The Most Disappointing Clinical Failures in 2014

Three Motley Fool contributors tell us what they think were the biggest drug trial failures this year.

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog

Weekly Market Wrap: December 19, 2014

Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More

Amgen Product Approvals Have Me Holding The Stock Tightly

Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog

Daily Dividend Report: AMGN, ZTS, WDR, IRC, SCHL, KYE

See More AMGN News...

AMGN's Top Competitors

AMGN $164.83 (-3.14%)
Current stock: AMGN
GILD $93.34 (-13.93%)
Current stock: GILD
CELG $114.05 (-2.67%)
Current stock: CELG
$0.00 (0.00%)
Current stock: